bp-legacy,page-template-default,page,page-id-84,woocommerce-no-js,ajax_fade,page_not_loaded,boxed,,qode-title-hidden,overlapping_content,columns-3,qode-theme-ver-7.5,wpb-js-composer js-comp-ver-6.0.2,vc_responsive,no-js
Cord Blood Banking

Currently, collection of umbilical cord blood is one of the most rapidly increasing obstetrical procedures. Every year thousands of new parents, including those who do not have illnesses in their family’s clinical history, decide to preserve their babies’ umbilical cord blood stem cells. After the mother enrolls in the service, she receives a collection kit with all the required elements. The kit must be preserved and stored in a safe place until the delivery date when she hands it over to the doctor. The doctor collects the cord blood from the umbilical cord immediately after the baby’s birth, but generally before the placenta is delivered. This is the only opportunity to harvest a newborn’s cord blood stem cells. Neither the mother, nor the baby feels any pain or are at risk during the collection process, which does not interfere with the delivery at all. The blood is taken from the cord once it has been clamped and cut. A needle is gently inserted into the thicker umbilical cord vein and the blood bag begins to fill with cord blood. The objective is to collect as much blood as possible to ensure a maximum amount of stem cells. Once the blood is finally collected, a label containing the mother’s and baby’s names as well as the date and time of delivery is placed on the front of the collection bag. The sample must remain at room temperature and should not be refrigerated. As soon as the process is finished, the cord blood sample is sent for processing to our cryogenic laboratory. This type of collection is safe for both traditional and cesarean deliveries.


After your child’s cord blood has been collected, it can be immediately shipped to our facility. All the necessary materials needed for processing the cord blood sample will arrive at our laboratory under controlled conditions in order to guarantee the safety and sterility of the unit. We process our client’s cord blood using a widely accepted and validated volume reduction system. This system is very efficient in recovering a high number of total nucleated cells needed for transplants. As part of our processing procedures we will test the cord blood samples for cell viability and total stem cells using flow cytometry. The cord blood will also be tested to determine the sterility and total nucleated cell count (TNC). The maternal blood collected at the time of delivery will be tested for infectious diseases. All our processing and testing takes place under the strictest quality control conditions.


To store our clients’ invaluable stem cells, we use the best scientifically developed techniques in the area of cryopreservation. First, we use special, compartmentalized cryobags. These bags include two storage chambers one being 20mls, the other 5ml (which could potentially be retained for stem cell expansion once this technology is developed). In addition the cryobags have 2 separate integrally attached segments for testing purposes i.e. HLA-typing. Then, a controlled-rate freezing process is used to prepare the cells for long-term storage. This technique is very important for maintaining the viability of the umbilical cord blood stem cells and for achieving the subsequent and necessary sustained cryogenic temperature in the cryogenic storage. Once the cells are brought to the optimum temperature, they are placed in an Teflon overwrap-bag for added protection and placed in a cryogenic storage cartridge, which then goes into the cryogenic storage tanks. Once the stem cells are properly and safely stored, you, the parent, as the child’s guardian, have control over their use and disposal. No stem cells can be released without the parent’s consent until the child reaches legal age, in which case control over the stem cells passes to him or her. Based on current research, stem cells can be successfully stored for 25 years in a cryogenic storage. Although not enough years have passed to assert the maximum length of time viable stem cells can be stored with certainty, bone marrow, another similar source of blood cells, has been successfully stored for decades and has remained viable throughout that time.


Always at the forefront of stem cell research, processing and cryopreservation, GeneCell International is also one of the few adipose tissue stem cell banks in the world.

Adipose (fat) tissue is a dynamic multi-functional tissue that is found throughout the human body. The stem cells originated from adipose tissue are mesenchymal stem cells which have the ability to differentiate into bone, muscle, fat, nerve, and cartilage. Preliminary research performed at GeneCell International has shown the presence of early stem cells markers as well.

Adipose-derived stem cells are easy to obtain through a simple and localized liposuction process using local anesthesia and with minimal patient discomfort. These autologous adult stem cells show the same morphology, immune phenotype and differentiation capacity as stem cells obtained from bone marrow and umbilical cord blood. They are free of ethical debate and use tissue which is abundant and easy to access. A single sample of adipose tissue can yield more than 200 million stem cells of which 95% are mesenchymal stem cells. These cells appear to be one of the body’s tools for self-repair.

Mesenchymal stem cells are capable of performing three important functions with unique abilities:

Plasticity: their potential to transform into other cell types.

Honing: they can travel to the damaged tissue.

Engraftment: their capability to attach themselves to the damaged tissue

Adipose-derived stem cells have the potential to treat a variety of different diseases and conditions that range from breast soft tissue reconstruction after tumor surgery to treatment of brain injuries, stroke, heart failure and more.

Currently, there are several clinical trials using adipose stem cells to treat a variety of disorders, including:

Traumatic Calvaria (skull-cap) Defects

Lipodystrophy I

Myocardial Infarction

Diabetes Type I

Diabetes Type II

Liver Cirrhosis

Maxillary Reconstruction

Chron’s Disease

Stem Cell Research and Development

This is being written now